Uday Kompella
Oprichter bij OCUGEN, INC.
Vermogen: 832 006 $ op 30-04-2024
Actieve functies van Uday Kompella
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OCUGEN, INC. | Directeur/Bestuurslid | 27-09-2019 | - |
| Oprichter | 01-01-2013 | - | |
| Independent Dir/Board Member | 27-09-2019 | - | |
| Ocugen OpCo, Inc. | Directeur/Bestuurslid | 01-09-2013 | - |
| Oprichter | 01-09-2013 | - | |
| CU Anschutz Medical Campus | Corporate Officer/Principal | - | - |
Loopbaan van Uday Kompella
Eerdere bekende functies van Uday Kompella
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Ocugen, Inc. /Old/
 Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Directeur/Bestuurslid | 01-01-2013 | - |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2013 | - | |
| Oprichter | 01-01-2013 | - |
Opleiding van Uday Kompella
| University of Southern California | Doctorate Degree |
| Birla Institute of Technology & Science | Undergraduate Degree |
| Jadavpur University | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| India | 3 |
| 2 |
Operationeel
| Director/Board Member | 3 |
| Founder | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Consumer Services | 5 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| OCUGEN, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Health Technology |
| Ocugen OpCo, Inc. |
- Beurs
- Insiders
- Uday Kompella
- Ervaring
